What if something hailed as a ‘cure for cancer’ got caught up in a legal battle among some of the biggest names in cancer treatment?
That’s the case with a pioneering therapy developed jointly by research teams in Philadelphia and Memphis. Tomorrow a judge will listen to all sides in the dispute in hopes of avoiding a trial.
From the Here & Now Contributors Network, Zack Seward of WHYY reports.
Reporter
- Zack Seward, innovations reporter at WHYY. He tweets @zackseward.
Copyright 2021 NPR. To see more, visit https://www.npr.org.